Darbas H, Jean-Pierre H, Paillisson J
Laboratoire de Bactériologie, Hôpital Armaud de Villeneuve, Montpellier, France.
J Clin Microbiol. 1994 Sep;32(9):2285-8. doi: 10.1128/jcm.32.9.2285-2288.1994.
Serratia ficaria was first described in 1979 as part of the fig tree ecosystem (P.A.D. Grimont, F. Grimont, and M. P. Starr, Curr. Microbiol. 2:277-282, 1979). Since then, it has been isolated from clinical specimens from a few human patients (C. Bollet, J. Freney, P. de Micco, F. Grimont, and P.A.D. Grimont, Méd. Mal. Infect. 20:97-100, 1990; J.A. Brouillard, W. Hansen, and A. Compere, J. Clin. Microbiol. 19:902-904, 1984; H. Darbas, H. Jean-Pierre, G. Boyer, and M. Riviere, Méd. Mal. Infect. 23:269-270, 1993; V.J. Gill, J.J. Farmer, III, P.A.D. Grimont, M.A. Asbury, and C.L. McIntosh, J. Clin. Microbiol. 14:234-236, 1981; F.D. Pien and J.J. Farmer III, South. Med. J. 76:1591-1592, 1983; C. Richard, J. de Coquet, and C. Suc, Méd. Mal. Infect. 19:45-47, 1989), but the pathogenicity of S. ficaria was always questionable. We are reporting the case of an aged cancer patient who developed S. ficaria septicemia. The habitat of this organism and its potential role as a pathogen are discussed.
无花果沙雷氏菌于1979年首次被描述为无花果生态系统的一部分(P.A.D. 格里蒙、F. 格里蒙和M.P. 斯塔尔,《当前微生物学》2:277 - 282,1979年)。从那时起,它已从少数人类患者的临床标本中分离出来(C. 博莱、J. 弗雷内、P. 德米科、F. 格里蒙和P.A.D. 格里蒙,《医学与感染》20:97 - 100,1990年;J.A. 布鲁illard、W. 汉森和A. 孔佩尔,《临床微生物学杂志》19:902 - 904,1984年;H. 达尔巴斯、H. 让 - 皮埃尔、G. 博耶尔和M. 里维耶,《医学与感染》23:269 - 270,1993年;V.J. 吉尔、J.J. 法默三世、P.A.D. 格里蒙、M.A. 阿斯伯里和C.L. 麦金托什,《临床微生物学杂志》14:234 - 236,1981年;F.D. 皮恩和J.J. 法默三世,《南方医学杂志》76:1591 - 1592,1983年;C. 理查德、J. 德科凯和C. 叙克,《医学与感染》19:45 - 47,1989年),但无花果沙雷氏菌的致病性一直存在疑问。我们报告一例老年癌症患者发生无花果沙雷氏菌败血症的病例。讨论了该生物体的栖息地及其作为病原体的潜在作用。